Controlled substance agreements between providers and patients represent important strategies for setting expectations for chronic opioid therapy. These agreements generally summarize best opioid prescription practices and destigmatize practice policies such as regular toxicology screenings. These controlled substance agreements also set expectations for discontinuation of therapy if appropriate.
Keywords: Chronic opioid prescription; Controlled substance agreements; Opioid prescribing best practices.
Copyright © 2020 Elsevier Inc. All rights reserved.
Paulozzi LJ, Strickler GK, Kreiner PW, Koris CM; Centers for Disease Control and Prevention (CDC). Paulozzi LJ, et al. MMWR Surveill Summ. 2015 Oct 16;64(9):1-14. doi: 10.15585/mmwr.ss6409a1. MMWR Surveill Summ. 2015. PMID: 26469747
Patchett D, Grover M, Kresin M, Bryan M, Nordrum J, Buras M, Pierce S, McDaniel K. Patchett D, et al. J Fam Pract. 2019 Jul/Aug;68(6):E1-E7. J Fam Pract. 2019. PMID: 31381628
Shields LB, Nasraty S, Bell AD, Vinayakan AN, Gudibanda RS, Hester ST, Honaker JT. Shields LB, et al. J Opioid Manag. 2016 Nov/Dec;12(6):397-403. doi: 10.5055/jom.2016.0359. J Opioid Manag. 2016. PMID: 28059432
Babington JR, Matthews M. Babington JR, et al. Phys Med Rehabil Clin N Am. 2020 May;31(2):279-287. doi: 10.1016/j.pmr.2020.01.004. Epub 2020 Mar 10. Phys Med Rehabil Clin N Am. 2020. PMID: 32279730 Review.
Bicket MC, Brat GA, Hutfless S, Wu CL, Nesbit SA, Alexander GC. Bicket MC, et al. Am J Health Syst Pharm. 2019 Sep 3;76(18):1403-1412. doi: 10.1093/ajhp/zxz146. Am J Health Syst Pharm. 2019. PMID: 31505561 Review.
Shah I, Sheth SG, Kothari DJ. Shah I, et al. World J Gastroenterol. 2021 Jun 21;27(23):3142-3147. doi: 10.3748/wjg.v27.i23.3142. World J Gastroenterol. 2021. PMID: 34163102 Free PMC article.